COURTNEY FAIRCHILD: Open Payments
NPI 1477019925 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,770 in 127 payments from 17 companies in 2025. Trend: 2023 $3,044 · 2024 $2,681 · 2025 $3,770
Food & beverage: $2,462Consulting: $1,140Education: $168
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $1,370 |
| ABBVIE INC. | 34 | $613 |
| Organogenesis Inc. | 8 | $295 |
| Janssen Biotech, Inc. | 11 | $262 |
| Novartis Pharmaceuticals Corporation | 10 | $247 |
| LEO Pharma Inc. | 13 | $202 |
| PFIZER INC. | 6 | $197 |
| Incyte Corporation | 9 | $135 |
| GENZYME CORPORATION | 4 | $108 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
Products named: Bimzelx, SKYRIZI, TREMFYA, DUPIXENT, CIBINQO, NOVACHOR, ADBRY, OPZELURA.
Industry payments across GA — which companies pay providers there.
